|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
15,961,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with hormone-dependent cancer. Co.'s business is dependent on the development, regulatory approval and commercialization of its therapeutic product candidates, ONA-XR and CLDN6xCD3 bsAb, which are in the early stages of development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
126,118 |
Total Buy Value |
$0 |
$0 |
$0 |
$138,453 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
12 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lehr Martin A. |
Chief Executive Officer |
|
2023-02-21 |
4 |
AB |
$0.84 |
$4,900 |
D/D |
5,823 |
159,701 |
|
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2023-02-13 |
4 |
AB |
$0.87 |
$4,901 |
D/D |
5,606 |
153,878 |
|
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2023-02-06 |
4 |
AB |
$0.97 |
$4,900 |
D/D |
5,040 |
148,272 |
|
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2023-01-30 |
4 |
AB |
$0.70 |
$4,901 |
D/D |
7,027 |
143,232 |
|
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2023-01-23 |
4 |
AB |
$0.72 |
$4,901 |
D/D |
6,839 |
136,205 |
|
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2023-01-17 |
4 |
AB |
$0.74 |
$4,995 |
D/D |
6,783 |
129,366 |
|
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2022-12-16 |
4 |
B |
$0.74 |
$14,796 |
D/D |
20,000 |
122,583 |
2.81 |
- |
|
Minai-Azary Jennifer Lynn |
Chief Financial Officer |
|
2022-12-16 |
4 |
B |
$0.74 |
$18,500 |
D/D |
25,000 |
40,000 |
2.74 |
- |
|
Levit Alex C. |
Chief Legal Officer, Corp. Sec |
|
2022-12-09 |
4 |
B |
$0.85 |
$5,095 |
D/D |
6,000 |
9,000 |
2.74 |
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2022-08-19 |
4 |
B |
$1.85 |
$24,064 |
D/D |
13,000 |
102,583 |
2.81 |
- |
|
Minai-Azary Jennifer Lynn |
Chief Financial Officer |
|
2022-08-17 |
4 |
B |
$1.80 |
$27,000 |
D/D |
15,000 |
15,000 |
2.74 |
- |
|
Sahmoud Tarek |
Chief Medical Officer |
|
2022-08-16 |
4 |
B |
$1.95 |
$19,500 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2021-12-16 |
4 |
B |
$3.22 |
$41,850 |
I/I |
13,000 |
820,190 |
2.66 |
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2021-10-22 |
4/A |
B |
$5.00 |
$50,000 |
I/I |
10,000 |
807,190 |
2.66 |
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2021-10-22 |
4/A |
A |
$0.00 |
$0 |
I/I |
797,190 |
797,190 |
|
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2021-10-22 |
4/A |
A |
$7.14 |
$376,135 |
I/I |
52,680 |
0 |
|
- |
|
Dick Evan G. |
SVP of R&D |
|
2021-10-22 |
4/A |
A |
$0.00 |
$0 |
D/D |
26,587 |
82,960 |
|
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2021-10-22 |
4 |
A |
$0.00 |
$0 |
I/I |
797,198 |
849,878 |
|
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2021-10-22 |
4 |
A |
$7.14 |
$376,135 |
I/I |
52,680 |
52,680 |
|
- |
|
Lehr Martin A. |
Chief Executive Officer |
|
2021-10-22 |
4 |
B |
$5.00 |
$50,000 |
D/D |
10,000 |
99,583 |
2.81 |
- |
|
Levit Alex C. |
Chief Legal Officer, Corp. Sec |
|
2021-10-22 |
4 |
B |
$5.00 |
$15,000 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
Dick Evan G. |
SVP of R&D |
|
2021-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
26,587 |
87,139 |
|
- |
|
Dick Evan G. |
SVP of R&DOfficer |
|
2021-10-19 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
56,373 |
|
- |
|
Dick Evan G. |
SVP of R&DOfficer |
|
2021-10-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,552 |
|
- |
|
Lehr Martin A. |
Chief Executive OfficerOfficer |
|
2021-10-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
89,583 |
|
- |
|
27 Records found
|
|
Page 1 of 2 |
|
|